Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2016 (2016), Article ID 7678486, 8 pages
http://dx.doi.org/10.1155/2016/7678486
Research Article

Synthesis, Characterization, and Anticancer Activity of New Benzofuran Substituted Chalcones

1Department of Chemistry, Faculty of Science, Fırat University, 23119 Elazığ, Turkey
2Department of Physiology, Faculty of Medicine, Inonu University, 44000 Malatya, Turkey

Received 6 April 2016; Revised 26 April 2016; Accepted 8 May 2016

Academic Editor: Grigoris Zoidis

Copyright © 2016 Demet Coşkun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-L. Chen, S.-Z. Lin, J.-Y. Chang et al., “In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells,” Biochemical Pharmacology, vol. 72, no. 3, pp. 308–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Abonia, D. Insuasty, J. Castillo et al., “Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity,” European Journal of Medicinal Chemistry, vol. 57, pp. 29–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. B.-Z. Ahn and D.-E. Sok, “Michael acceptors as a tool for anticancer drug design,” Current Pharmaceutical Design, vol. 2, no. 3, pp. 247–262, 1996. View at Google Scholar · View at Scopus
  4. Z. Nowakowska, “A review of anti-infective and anti-inflammatory chalcones,” European Journal of Medicinal Chemistry, vol. 42, no. 2, pp. 125–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. X.-W. Zhang, D.-H. Zhao, Y.-C. Quan, L.-P. Sun, X.-M. Yin, and L.-P. Guan, “Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives,” Medicinal Chemistry Research, vol. 19, no. 4, pp. 403–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Iqbal, V. Prabhakar, A. Sangith, B. Chandrika, and R. Balasubramanian, “Synthesis, anti-inflammatory and antioxidant activity of ring-a-monosubstituted chalcone derivatives,” Medicinal Chemistry Research, vol. 23, no. 10, pp. 4383–4394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Wan, L. Xu, L. Hua et al., “Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents,” Bioorganic Chemistry, vol. 54, pp. 38–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Agarwal, K. Srivastava, S. K. Puri, and P. M. S. Chauhan, “Antimalarial activity and synthesis of new trisubstituted pyrimidines,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 12, pp. 3130–3132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. L. Go, X. Wu, and X. L. Liu, “Chalcones: an update on cytotoxic and chemoprotective properties,” Current Medicinal Chemistry, vol. 12, no. 4, pp. 483–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Sivakumar, S. Ganesan, P. Veluchamy, and M. Doble, “Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents,” Chemical Biology & Drug Design, vol. 76, no. 5, pp. 407–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Adibi, J. S. Mojarrad, H. Asgharloo, and G. Zarrini, “Synthesis, in vitro antimicrobial and antioxidant activities of chalcone and flavone derivatives holding allylic substitutions,” Medicinal Chemistry Research, vol. 20, no. 8, pp. 1318–1324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Parikh and D. Joshi, “Antibacterial and antifungal screening of newly synthesized benzimidazole-clubbed chalcone derivatives,” Medicinal Chemistry Research, vol. 22, no. 8, pp. 3688–3697, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Aponte, M. Verástegui, E. Málaga et al., “Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones,” Journal of Medicinal Chemistry, vol. 51, no. 19, pp. 6230–6234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Shah, A. M. Khan, R. Qureshi, F. L. Ansari, M. F. Nazar, and S. S. Shah, “Redox behavior of anticancer chalcone on a glassy carbon electrode and evaluation of its interaction parameters with DNA,” International Journal of Molecular Sciences, vol. 9, no. 8, pp. 1424–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Quintin, J. Desrivot, S. Thoret, P. L. Menez, T. Cresteil, and G. Lewin, “Synthesis and biological evaluation of a series of tangeretin-derived chalcones,” Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 1, pp. 167–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. N. Mokale, P. N. Dube, S. A. Bhavale et al., “Synthesis, in-vitro screening, and docking analysis of novel pyrrolidine and piperidine-substituted ethoxy chalcone as anticancer agents,” Medicinal Chemistry Research, vol. 24, no. 5, pp. 1842–1856, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Maggiolini, G. Statti, A. Vivacqua et al., “Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 82, no. 4-5, pp. 315–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Sakai, R. N. Eskander, Y. Guo et al., “Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines,” Journal of Orthopaedic Research, vol. 30, no. 7, pp. 1045–1050, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Kumar, E. Hager, C. Pettit, H. Gurulingappa, N. E. Davidson, and S. R. Khan, “Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents,” Journal of Medicinal Chemistry, vol. 46, no. 14, pp. 2813–2815, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Srinivasan, T. E. Johnson, R. Lad, and C. Xing, “Structure—activity relationship studies of chalcone leading to 3-hydroxy-4,3′,4′,5′-tetramethoxychalcone and its analogues as potent nuclear factor κB inhibitors and their anticancer activities,” Journal of Medicinal Chemistry, vol. 52, no. 22, pp. 7228–7235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Kumar, N. M. Kumar, K. Akamatsu, E. Kusaka, H. Harada, and T. Ito, “Synthesis and biological evaluation of indolyl chalcones as antitumor agents,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 13, pp. 3916–3919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-H. Kim, E. Lee, K. H. Baek et al., “Chalcones, inhibitors for topoisomerase i and cathepsin B and L, as potential anti-cancer agents,” Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 11, pp. 3320–3324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-J. Zhang, Y. Qian, D.-D. Zhu, X.-G. Yang, and H.-L. Zhu, “Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents,” European Journal of Medicinal Chemistry, vol. 46, no. 9, pp. 4702–4708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Kamal, J. S. Reddy, M. J. Ramaiah et al., “Design, synthesis and biological evaluation of imidazopyridine/pyrimidine- chalcone derivatives as potential anticancer agents,” Medicinal Chemical Communications, vol. 1, no. 5, pp. 355–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Sharma, B. Chakravarti, M. P. Gupt, J. A. Siddiqui, R. Konwar, and R. P. Tripathi, “Synthesis and anti breast cancer activity of biphenyl based chalcones,” Bioorganic and Medicinal Chemistry, vol. 18, no. 13, pp. 4711–4720, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Juvale, V. F. S. Pape, and M. Wiese, “Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein,” Bioorganic and Medicinal Chemistry, vol. 20, no. 1, pp. 346–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Ugale, H. Patel, B. Patel, and S. Bari, “Benzofurano-isatins: search for antimicrobial agents,” Arabian Journal of Chemistry, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-L. Kao and J.-W. Chern, “A convenient synthesis of naturally occurring benzofuran ailanthoidol,” Tetrahedron Letters, vol. 42, no. 6, pp. 1111–1113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Basawaraj, B. Yadav, and S. S. Sangapure, “Synthesis of some 1H-pyrazolines bearing benzofuran as biologically active agents,” Indian Journal of Heterocyclic Chemistry, vol. 11, no. 1, pp. 31–34, 2001. View at Google Scholar · View at Scopus
  30. S. M. Rida, S. A. M. El-Hawash, H. T. Y. Fahmy, A. A. Hazzaa, and M. M. M. El-Meligy, “Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti-HIV-1, anticancer and antimicrobial activities,” Archives of Pharmacal Research, vol. 29, no. 10, pp. 826–833, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. K. Ujjinamatada, R. S. Appala, and Y. S. Agasimundin, “Synthesis and antimicrobial activity of new benzofuranyl-1,3-benzoxazines and 1,3-benzoxazin-2-ones,” Journal of Heterocyclic Chemistry, vol. 43, no. 2, pp. 437–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Romagnoli, P. G. Baraldi, T. Sarkar et al., “Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agents,” Medicinal Chemistry, vol. 4, no. 6, pp. 558–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. C. Mayur, G. J. Peters, V. V. S. Rajendra Prasad, C. Lemos, and N. K. Sathish, “Design of new drug molecules to be used in reversing multidrug resistance in cancer cells,” Current Cancer Drug Targets, vol. 9, no. 3, pp. 298–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. V. R. Solomon, C. Hu, and H. Lee, “Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity,” Bioorganic and Medicinal Chemistry, vol. 17, no. 21, pp. 7585–7592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Coşkun and M. Ahmedzade, “3-(Substituted aryl)-1-(benzofuran-2-yl)-2-propenones, part 1: synthesis and characterization of some novel chalcones,” Synthetic Communications, vol. 38, no. 21, pp. 3613–3622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Küçükbay, A. Mumcu, S. Tekin, and S. Sandal, “Synthesis and evaluation of novel N,N'-disubstituted benzimidazolium bromides salts as antitumor agents,” Turkish Journal of Chemistry, vol. 40, pp. 393–401, 2016. View at Publisher · View at Google Scholar
  37. N. Kolocouris, G. B. Foscolos, A. Kolocouris et al., “Synthesis and antiviral activity evaluation of some aminoadamantane derivatives,” Journal of Medicinal Chemistry, vol. 37, no. 18, pp. 2896–2902, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. A. O. Görgülü, K. Koran, F. Özen, S. Tekin, and S. Sandal, “Synthesis, structural characterization and anti-carcinogenic activity of new cyclotriphosphazenes containing dioxybiphenyl and chalcone groups,” Journal of Molecular Structure, vol. 1087, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. R. A. Kabli, A. A. Khalaf, M. T. Zimaity, A. M. Khalil, A. M. Kaddah, and H. A. Al-Rifaie, “Synthesıs of a new serıes of furyl and thıenyl substıtuted pyrazolınes startıng wıth furyl and thıenyl chalcones,” Journal of the Indian Chemical Society, vol. 68, pp. 47–51, 1991. View at Google Scholar
  40. B. S. Holla, P. M. Akberali, and M. K. Shivananda, “Studies on arylfuran derivatives: part X. Synthesis and antibacterial properties of arylfuryl-Δ2-pyrazolines,” Farmaco, vol. 55, no. 4, pp. 256–263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Cabrera, M. Simoens, G. Falchi et al., “Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships,” Bioorganic and Medicinal Chemistry, vol. 15, no. 10, pp. 3356–3367, 2007. View at Publisher · View at Google Scholar · View at Scopus